Journal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 6, Issue 5, Pages 601-618Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14787210.6.5.601
Keywords
ceftaroline; ceftobiprole; community-associated methicillin-resistant Staphylococcus aureus; dalbavancin; daptomycin; iclaprim; linezolid; methicillin-resistant S. aureus treatment; oritavancin; quinupristin-dalfopristin; telavancin; tigecycline; tomopenem
Ask authors/readers for more resources
This review looks at the challenges facing the worldwide community with the increasing problem of methicillin resistance in Staphylococcus aureus. The epidemiology and natural history of community-associated methicillin-resistant Staphylococcus aureus and the challenge of control is discussed. Options for treatment and review of key antimicrobial agents acting against methicillin-resistant S. aureus, both currently in use and in development, are addressed. There are a number of new agents, the place of which in therapeutic regimens is yet to emerge. The review attempts to inform the reader of the probable position of these agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available